Sever v. Glickman

298 F. Supp. 2d 267, 2004 U.S. Dist. LEXIS 373, 2004 WL 61050
CourtDistrict Court, D. Connecticut
DecidedJanuary 9, 2004
DocketCIV.3:02 CV 00722
StatusPublished
Cited by5 cases

This text of 298 F. Supp. 2d 267 (Sever v. Glickman) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sever v. Glickman, 298 F. Supp. 2d 267, 2004 U.S. Dist. LEXIS 373, 2004 WL 61050 (D. Conn. 2004).

Opinion

RULING ON THE PLAINTIFF’S MOTION TO DISMISS THE DEFENDANT DELCATH SYSTEM, INC.’S COUNTERCLAIM

COVELLO, District Judge.

This is an action for compensatory and punitive damages arising out of the alleged theft of an invention of a medical catheter device. It is brought pursuant to common law tenets concerning fraud, conversion, and civil conspiracy.

On April 25, 2002, the plaintiff, Frank Sever, Jr., commenced this action against Morton G. Glickman, Delcath Systems, Inc. (“Delcath”), and Stephen E. Feldman. On April 8, 2003, Delcath filed counterclaims alleging breach of contract, breach of implied covenants of good faith and fair dealing, breach of a fiduciary duty, and professional malpractice. On April 30, 2003, Sever filed the within motion to dismiss the counterclaims pursuant to Fed.R.Civ.P. 12(b)(6) and 12(b)(7), contending that a cause of action is not stated and that Delcath had failed to join a necessary party under Fed.R.Civ.P. 19.

The issues presented are: 1) whether the allegations set forth in the counter *269 claim demonstrate that a contract existed between Delcath and Sever; 2) whether the allegations set forth in the counterclaim establish a cause of action for breach of the implied covenants of good faith and fair dealing; 3) whether the allegations set forth in the counterclaim establish a cause of action for breach of fiduciary duty; 4) whether the allegations set forth in the counterclaim establish a cause of action for malpractice by Sever; 5) whether Feldman is a necessary party under Fed.R.Civ.P. 19, such that the court is required to dismiss the counterclaim pursuant to Fed. R.Civ.P. 12(b)(7).

For the reasons that follow, the court concludes that: 1) the allegations in the complaint do not set forth the existence of a contract; 2) because no contract is alleged, the cause of action for breach of the implied covenant of good faith and fair dealing fails; 3) the allegations in the complaint set forth a cause of action for breach of a fiduciary duty; 4) the allegations of the complaint set forth in the complaint set forth a cause of action for malpractice; and 5) Feldman is not a necessary party and therefore dismissal pursuant to Fed.R.Civ.P. 12(b)(7) is not warranted.

Accordingly, the motion to dismiss (document no. 66) is GRANTED in part, and DENIED in part.

FACTS

The counterclaim alleges that: Sever is a patent attorney admitted to practice before the United States Patent and Trademark Office. “Over the years, Sever has asked for work assignments from Stephen E. Feldman P.C., a patent law firm based in New York City, on behalf of clients of Feldman, ... including defendant Del-cath.” Consequently, “Sever has performed legal services on behalf of said clients and rendered legal services to said clients.” The counterclaim further alleges that “[e]ach time Feldman ... on behalf of its clients, retained Sever to perform legal services on such clients’ behalf and render legal advice to said clients, an attorney-client relationship arose between Sever and each such client.”

Glickman, a physician, “has worked with and/or on behalf of Delcath on the development of medical devices for treating cancer.” On April 15, 1993, at Delcath’s offices, “Glickman disclosed his design of a telescoping lateral movement catheter controller.”

Feldman ... has served “for years as Delcath’s regular outside patent counsel.” “In 1994, Feldman ... was requested by Delcath to provide legal advice in support of the aforementioned Glickman/Delcath catheter controller.” “In February, 1997, ... Feldman, on behalf of Delcath, retained Sever’s legal services to assist Del-cath in connection with the preparation of a patent application” for Glickman’s invention. Feldman sent Sever the file relating to the invention and “requested that Sever prepare the application on Delcath’s behalf.” Included within the file forwarded to Sever were the results of a search performed at the Patent and Trademark Office (“PTO”) previously performed by Feldman and the drawings and disclosure of Glickman’s invention.

During February and March 1997, “Sever prepared a draft patent application on behalf of Delcath” (the “March 1997 application”). The March 1997 application was based on Glickman’s “design of a catheter controller that employed a finger trap or clamping arrangement.” Sever subsequently forwarded the March 1997 application to Feldman who forwarded it to both Glickman and Delcath.

“In mid-March, 1997, Feldman caused an updated search to be performed at the PTO.” The March 1997 search “confirmed *270 the existence of a prior patent for a catheter flow device held by one of Delcath’s supplier’s (the ‘supplier patent’).” In May, 1997, after ordering the prosecution file history for the supplier patent, Feldman sent the file history to Sever “to obtain his input and legal advice as to whether such prior patent presented a problem and, if so, how one might design around the claims in the supplier patent and thereby avoid infringement.” “On or about May 22, 1997, Sever sent a letter to Feldman indicating that the controller designed by Gliekman ... avoided the claims of the supplier patent.” Additionally, Sever suggested an alternate design to avoid any claims of the supplier patent. This alternate design suggested the use of an “incompressible fluid” in Glickman’s invention (the “incompressible fluid concept”). On May 30, 1997, Sever sent a letter to Feld-man which revised his May 22, 1997 letter. In May 1997, Sever also prepared a second patent application that incorporated the incompressible fluid concept. That application was forwarded to Delcath by Feld-man, at Sever’s urging. Delcath subsequently informed Feldman that it was not interested in the incompressible fluid concept and Feldman so informed Sever.

Feldman told Sever that Delcath would file a patent in accordance with the March 1997 patent application prepared by Sever. Sever expressed to Feldman that he intended to file a patent based on the incompressible fluid concept in his own name and on his own behalf.

On September 2, 1997, “Feldman, on Delcath’s behalf, submitted a patent application on Glickman’s invention.” In April 1999, “the application resulted in the issuance of U.S. Patent No. 5,897,533 (the ’533 patent).”

On June 28,1999, without any authorization from Feldman or Delcath, “Sever filed a patent application on his own behalf in his own name.” The June 28, 1999 application “was a copy of the patent application that Sever had prepared for Delcath in May of 1997,” which included the incompressible fluid concept.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sunset Homeowners Ass'n, Inc. v. Difrancesco
386 F. Supp. 3d 299 (W.D. New York, 2019)
Downing v. Globe Direct LLC
806 F. Supp. 2d 461 (D. Massachusetts, 2011)
Blacksmith Investments, LLC. v. Cives Steel Co.
228 F.R.D. 66 (D. Massachusetts, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
298 F. Supp. 2d 267, 2004 U.S. Dist. LEXIS 373, 2004 WL 61050, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sever-v-glickman-ctd-2004.